These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 35756606)

  • 1. Exosomal miR-4800-3p Aggravates the Progression of Hepatocellular Carcinoma
    Lin H; Peng J; Zhu T; Xiong M; Zhang R; Lei L
    Front Oncol; 2022; 12():759864. PubMed ID: 35756606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Jianpi Huayu decoction inhibits the epithelial-mesenchymal transition of hepatocellular carcinoma cells by suppressing exosomal miR-23a-3p/Smad signaling.
    Xie CF; Feng KL; Wang JN; Luo R; Fang CK; Zhang Y; Shen CP; Zhong C
    J Ethnopharmacol; 2022 Aug; 294():115360. PubMed ID: 35568116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomal lncRNA H19 promotes the progression of hepatocellular carcinoma treated with Propofol via miR-520a-3p/LIMK1 axis.
    Wang D; Xing N; Yang T; Liu J; Zhao H; He J; Ai Y; Yang J
    Cancer Med; 2020 Oct; 9(19):7218-7230. PubMed ID: 32767662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomes secreted by M2 macrophages promote cancer stemness of hepatocellular carcinoma via the miR-27a-3p/TXNIP pathways.
    Li W; Xin X; Li X; Geng J; Sun Y
    Int Immunopharmacol; 2021 Dec; 101(Pt A):107585. PubMed ID: 34601333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-23b-3p suppresses epithelial-mesenchymal transition, migration, and invasion of hepatocellular carcinoma cells by targeting c-MET.
    Park NR; Cha JH; Sung PS; Jang JW; Choi JY; Yoon SK; Bae SH
    Heliyon; 2022 Oct; 8(10):e11135. PubMed ID: 36281372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosome-delivered miR-410-3p reverses epithelial-mesenchymal transition, migration and invasion of trophoblasts in spontaneous abortion.
    Chen ZY; Li Z; Zong Y; Xia B; Luo SP; Deng GP; Gao J
    J Cell Mol Med; 2024 Feb; 28(3):e18097. PubMed ID: 38164738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Golgi phosphoprotein 3 promotes angiogenesis and sorafenib resistance in hepatocellular carcinoma via upregulating exosomal miR-494-3p.
    Gao Y; Yin Z; Qi Y; Peng H; Ma W; Wang R; Li W
    Cancer Cell Int; 2022 Jan; 22(1):35. PubMed ID: 35073936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-128-3p suppresses tumor proliferation and metastasis via targeting CDC6 in hepatocellular carcinoma cells.
    Shi Y; Yan F; Wang F; Pan L
    Tissue Cell; 2021 Oct; 72():101534. PubMed ID: 33991762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal circ_0032704 confers sorafenib resistance to hepatocellular carcinoma and contributes to cancer malignant progression by modulating the miR-514a-3p/PD-L1 pathway.
    Dou C; Zhu H; Xie X; Huang C; Tan H; Cao C
    Ann Gastroenterol Surg; 2024 May; 8(3):507-520. PubMed ID: 38707229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p- TGF-β1 axis.
    Shang A; Gu C; Wang W; Wang X; Sun J; Zeng B; Chen C; Chang W; Ping Y; Ji P; Wu J; Quan W; Yao Y; Zhou Y; Sun Z; Li D
    Mol Cancer; 2020 Jul; 19(1):117. PubMed ID: 32713345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer-associated fibroblasts-secreted exosomal miR-92a-3p promotes tumor growth and stemness in hepatocellular carcinoma through activation of Wnt/β-catenin signaling pathway by suppressing AXIN1.
    Su Z; Lu C; Zhang F; Liu H; Li M; Qiao M; Zou X; Luo D; Li H; He M; Se H; Jing J; Wang X; Yang H; Yang H
    J Cell Physiol; 2024 Jul; ():. PubMed ID: 38949237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating PTEN/Akt pathway in hepatocellular carcinoma.
    Yang B; Feng X; Liu H; Tong R; Wu J; Li C; Yu H; Chen Y; Cheng Q; Chen J; Cai X; Wu W; Lu Y; Hu J; Liang K; Lv Z; Wu J; Zheng S
    Oncogene; 2020 Oct; 39(42):6529-6543. PubMed ID: 32917956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer.
    Hu JL; Wang W; Lan XL; Zeng ZC; Liang YS; Yan YR; Song FY; Wang FF; Zhu XH; Liao WJ; Liao WT; Ding YQ; Liang L
    Mol Cancer; 2019 May; 18(1):91. PubMed ID: 31064356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosome-depleted MiR-148a-3p derived from Hepatic Stellate Cells Promotes Tumor Progression via ITGA5/PI3K/Akt Axis in Hepatocellular Carcinoma.
    Zhang X; Chen F; Huang P; Wang X; Zhou K; Zhou C; Yu L; Peng Y; Fan J; Zhou J; Lu Z; Hu J; Wang Z
    Int J Biol Sci; 2022; 18(6):2249-2260. PubMed ID: 35414782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow mesenchymal stem cell-derived exosomal MiR-338-3p represses progression of hepatocellular carcinoma by targeting ETS1.
    Li YH; Lv MF; Lu MS; Bi JP
    J Biol Regul Homeost Agents; 2021; 35(2):617-627. PubMed ID: 33884828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hsa_circRNA_102610 upregulation in Crohn's disease promotes transforming growth factor-β1-induced epithelial-mesenchymal transition
    Yin J; Ye YL; Hu T; Xu LJ; Zhang LP; Ji RN; Li P; Chen Q; Zhu JY; Pang Z
    World J Gastroenterol; 2020 Jun; 26(22):3034-3055. PubMed ID: 32587447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma.
    Wu G; Zheng K; Xia S; Wang Y; Meng X; Qin X; Cheng Y
    J Exp Clin Cancer Res; 2016 Jun; 35(1):89. PubMed ID: 27259866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA SNHG1 promotes cell progression and metastasis via sponging miR-377-3p in hepatocellular carcinoma.
    Qu A; Yang Q
    Neoplasma; 2020 May; 67(3):557-566. PubMed ID: 32122143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of miR-541-3p/TMPRSS4 in the metastasis and EMT of hepatocellular carcinoma.
    Xia YH; Ren L; Li JZ; Gao F
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10721-10728. PubMed ID: 31858539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-143-3p inhibits proliferation and invasion of hepatocellular carcinoma cells by regulating its target gene FGF1.
    Peng J; Wu HJ; Zhang HF; Fang SQ; Zeng R
    Clin Transl Oncol; 2021 Mar; 23(3):468-480. PubMed ID: 32617870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.